IMPORTANCE More than 1 million older adults develop heart failure annually. The association of alcohol consumption with survival among these individuals after diagnosis is unknown.
Introduction
The association between alcohol consumption and heart failure (HF) is complex. Although excessive alcohol consumption may result in HF due to an alcoholic cardiomyopathy, 1,2 moderate alcohol consumption has been associated with a reduction in the risk of incident HF. [3] [4] [5] [6] However, a more recent analysis suggests that alcohol consumption of more than approximately 7 drinks per week is associated with an increased hazard of HF, with a neutral association observed with less alcohol consumption. 7 In contrast to the conflicting data regarding the association between previous alcohol consumption and development of HF, to our knowledge, there are no data regarding the safety of alcohol consumption in patients following a new diagnosis of HF. Previous studies examining alcohol use in adults with HF have yielded mixed results, but they were limited to individuals with prevalent disease. [8] [9] [10] [11] Thus, the possibility of a survivor bias influencing these results cannot be excluded. With more than 1 million new cases of HF diagnosed annually in the United States among individuals 55 years or older, 12 data regarding the association of alcohol consumption in this population is lacking.
We sought to examine the association between alcohol consumption and survival following the diagnosis of HF in a cohort of older adults in a community setting.
Methods
This investigation conforms to the principles outlined in the Declaration of Helsinki. 13 Because Cardiovascular Health Study data were deidentified, the Washington University Office of Human Baseline alcohol consumption was determined at the initial visit, and former drinkers were differentiated from abstainers (never drinkers). 5 Alcohol consumption was ascertained in a similar manner during follow-up years 2 through 5 and years 7 through 9 but was not obtained in follow-up years 1 and 6 for administrative reasons. 5 To allow for assessment of alcohol consumption during the first visit after the diagnosis of HF, only patients with incident HF diagnosed during the first 10 years health (sick quitters), and we were interested in examining how continued alcohol consumption after diagnosis of HF was related to survival compared with long-term abstinence.
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We used multiple linear regression to model the association between alcohol consumption as a categorical variable and subsequent survival (time from diagnosis of HF to death or last follow-up) 19 after adjustment for age, sex, race/ethnicity, educational level, income, smoking status, marital status, hypertension, diabetes, stroke, myocardial infarction, atrial fibrillation, angiotensinconverting enzyme inhibitor use, β-blocker use, systolic blood pressure, diastolic blood pressure, body mass index, 15-ft walk time, glomerular filtration rate, and the presence of left ventricular hypertrophy reported on the electrocardiogram. β-Blocker and angiotensin-converting enzyme inhibitor use was ascertained in the first visit following the diagnosis of HF. Hypertension and weight were determined from the visit immediately before HF diagnosis. Glomerular filtration rate, smoking status, marital status, systolic blood pressure, diastolic blood pressure, 15-ft walk time, left ventricular hypertrophy reported by electrocardiogram, and height were ascertained from the closest visit before or after the diagnosis of HF. Alcohol use assessment was ascertained at the first visit after the diagnosis except among 22 participants who had missing data. In those cases, we used the value immediately before the diagnosis was made, to which the mean difference in alcohol consumption before and after the diagnosis derived from individuals with both values was added.
A 2-sided P < .05 defined statistical significance. Multiple linear regression has previously been used in this data set to model associations between exposures and survival. 19 Model assumptions were evaluated by examining residual plots. After excluding former drinkers, we also assessed alcohol use as a continuous variable, including a quadratic term to test for an inverted U-shaped association between alcohol use and survival and adjustment for the same covariates. Mean estimates of time from incident HF to death along with 95% CIs were subsequently derived from the multivariable models. Sequential methods were used to impute missing baseline data. 20 All analyses were conducted using SAS, version 9.4 (SAS Institute Inc).
Results
Of Although robustness was limited by the small number of individuals who consumed more than 7 drinks per week, a significant inverted U-shaped association between alcohol consumption and survival was observed ( Figure) . Multivariable model estimates of mean time from heart failure diagnosis and death were 2640 days (95% CI, 1967-3313 days) for never drinkers, 3046 days (95% CI, 2372-3719 days) for consumers of 1 to 7 drinks per week, and 2806 days (95% CI, 1879-3734 days)
for consumers of more than 7 drinks per week (P = .02) (Figure) . Consumption of 10 drinks per week was associated with the longest survival, a mean of 3381 days (95% CI, 2806-3956 days) after heart failure diagnosis.
Discussion
Among community-dwelling older adults, alcohol consumption of 7 or fewer drinks per week after the diagnosis of HF was associated with longer survival compared with abstinence, after adjustment Mean estimates of time from incident heart failure to death or last follow-up were derived from a multivariable model that included linear and quadratic terms for alcohol consumption and that was adjusted for age, sex, race/ethnicity, educational level, income, smoking status, marital status, hypertension, diabetes, stroke, myocardial infarction, atrial fibrillation, angiotensin-converting enzyme inhibitor and β-blocker use, systolic blood pressure, diastolic blood pressure, body mass index, 15-ft walk time, glomerular filtration rate, and presence of left ventricular hypertrophy on electrocardiography.
Our findings of increased survival among community-dwelling older adults with HF and moderate alcohol consumption are consistent with observations reported in other studies in the population of patients without HF. [21] [22] [23] Moderate alcohol consumption appears to be protective against coronary atherosclerotic events, perhaps because of increases in high-density lipoprotein concentration, reductions in plasminogen activator, increases in plasminogen activator inhibitor activities, and improvement in insulin sensitivity. 24 Nevertheless, our findings should not be used to recommend that individuals who are newly diagnosed with HF should initiate alcohol consumption if they had formerly been abstainers.
Likewise, patients with suspected alcohol-induced cardiomyopathy should continue to abstain from alcohol consumption.
Limitations
Our study had several limitations. We used a single measure of alcohol consumption after the diagnosis of HF and could not adjust for the association between subsequent changes in alcohol consumption levels and survival. We did not have information about the cause of HF or about left ventricular ejection fraction and cannot comment whether the associations of alcohol consumption and survival differed among patients with reduced vs preserved left ventricular ejection fraction.
Given the limitations of our sample size, we did not perform subgroup analyses by age or sex. In addition, the group of patients who consumed more than 7 drinks per week after the diagnosis of HF consisted of only 17 individuals, limiting any conclusions that can be drawn about higher levels of alcohol consumption. Despite attempts to control for important covariates, we cannot exclude the possibility of residual confounding between alcohol use and other favorable prognostic factors influencing its observed association with improved survival.
Conclusions
Alcohol use is common among older adults who have been diagnosed with HF. These findings suggest that limited alcohol consumption among older adults with incident HF is associated with survival benefit compared with long-term abstinence. Given the possibility of health benefits with limited alcohol consumption following this diagnosis, further efforts to determine optimal levels of alcohol consumption in adults with HF and whether this differs by age, sex, left ventricular ejection fraction, or cause of HF are warranted.
